Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 7977-7991

  Yan, Huan ^a,b   Peng, Bo ^a   He, Wenhui ^a,c   Zhong, Guocai ^a   Qi, Yonghe ^a,d   Ren, Bijie ^a   Gao, Zhenchao ^a,b   Jing, Zhiyi ^a   Song, Mei ^a,c   Xu, Guangwei ^a   Sui, Jianhua ^a   Li, Wenhui ^a  

^a NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^b PEKING UNIVERSITY   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d BEIJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROLIPOAMIDE DEHYDROGENASE; RECEPTOR PROTEIN; SODIUM TAUROCHOLATE CONTRANSPORTING POLYPEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SEQUENCE ALIGNMENT; SUBSTITUTION REACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS INFECTIVITY;

ANIMALS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCEIN-5-ISOTHIOCYANATE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMANS; MICE; MICROSCOPY, FLUORESCENCE; MUTATION; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PROTEIN PRECURSORS; SYMPORTERS; TAUROCHOLIC ACID; TRITIUM; VERO CELLS; VIRUS INTERNALIZATION;

EID: 84880320667     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03540-12     Document Type: Article

References (45)

1. Ganem D, Prince AM. 2004. Hepatitis B virus infection: natural history and clinical consequences. N. Engl. J. Med. 350:1118-1129.
2. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11:97-107.
3. Chan HL, Sung JJ. 2006. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 26:153-161.
4. Hughes SA, Wedemeyer H, Harrison PM. 2011. Hepatitis delta virus. Lancet 378:73-85.
5. Nassal M. 1996. Hepatitis B virus morphogenesis. Curr. Top. Microbiol. Immunol. 214:297-337.
6. Kuo MY, Goldberg J, Coates L, Mason W, Gerin J, Taylor J. 1988. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J. Virol. 62:1855-1861.
7. Bonino F, Heermann KH, Rizzetto M, Gerlich WH. 1986. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virusderived envelope. J. Virol. 58:945-950.
8. Barrera A, Guerra B, Lee H, Lanford RE. 2004. Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitisD virus pseudotypes. J. Virol. 78:5233-5243.
9. Sureau C. 2006. The role of the HBV envelope proteins in the HDV replication cycle. Curr. Top. Microbiol. Immunol. 307:113-131.
10. Blanchet M, Sureau C. 2007. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J. Virol. 81:5841-5849.
11. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L, Song M, Chen P, Gao W, Ren B, Sun Y, Cai T, Feng X, Sui J, Li W. 2012. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1:e00049. doi:10.7554/eLife.00049.
12. Zhong G, Yan H, Wang H, He W, Jing Z, Qi Y, Fu L, Gao Z, Huang Y, Xu G, Feng X, Sui J, Li W. 2013. Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. J. Virol. 87:7176-7184.
13. Hagenbuch B, Meier PJ. 1994. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J. Clin. Invest. 93:1326-1331.
14. Stieger B. 2011. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb. Exp. Pharmacol. 201:205-259.
15. Ananthanarayanan M, Ng OC, Boyer JL, Suchy FJ. 1994. Characterization of cloned rat liver Na+-bile acid cotransporter using peptide and fusion protein antibodies. Am. J. Physiol. 267:G637-G643.
16. Stieger B, Hagenbuch B, Landmann L, Hochli M, Schroeder A, Meier PJ. 1994. In situ localization of the hepatocytic Na+/taurocholate cotransporting polypeptide in rat liver. Gastroenterology 107:1781-1787.
17. Barker LF, Maynard JE, Purcell RH, Hoofnagle JH, Berquist KR, London WT. 1975. Viral hepatitis, type B, in experimental animals. Am. J. Med. Sci. 270:189-195.
18. Su JJ. 1987. Experimental infection of human hepatitis B virus (HBV) in adult tree shrews. Zhonghua Bing Li Xue Za Zhi 16:103-122. (In Chinese.)
19. Walter E, Keist R, Niederost B, Pult I, Blum HE. 1996. Hepatitis B virus infection of Tupaia hepatocytes in vitro and in vivo. Hepatology 24:1-5.
20. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. 2003. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 77:9511-9521.
21. Guidotti LG, Matzke B, Schaller H, Chisari FV. 1995. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69:6158-6169.
22. Lucifora J, Vincent IE, Berthillon P, Dupinay T, Michelet M, Protzer U, Zoulim F, Durantel D, Trepo C, Chemin I. 2010. Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model. Hepatology 51:1954-1960.
23. Polo JM, Jeng KS, Lim B, Govindarajan S, Hofman F, Sanqiorqi F, Lai MM. 1995. Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J. Virol. 69:4880-4887.
24. Schieck A, Schulze A, Gahler C, Muller T, Haberkorn U, Alexandrov A, Urban S, Mier W. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology, in press. doi:10.1002/hep.26211.
25. Meier A, Mehrle S, Weiss TS, Mier W, Urban S. The myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology, in press. doi:10.1002/hep.26181.
26. Petersen J, Dandri M, Mier W, Lutgehetmann M, Volz T, von Weizsacker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S. 2008. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 26:335-341.
27. Sureau C, Moriarty AM, Thornton GB, Lanford RE. 1992. Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J. Virol. 66:1241-1245.
28. Blanchet M, Sureau C. 2006. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J. Virol. 80:11935-11945.
29. Van Dyke RW, Stephens JE, Scharschmidt BF. 1982. Bile acid transport in cultured rat hepatocytes. Am. J. Physiol. 243:G484-G492.
30. Schieck A, Schulze A, Gahler C, Muller T, Haberkorn U, Alexandrov A, Urban S, Mier W. 2013. Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology doi:10.1002/hep.26211.
31. Hu NJ, Iwata S, Cameron AD, Drew D. 2011. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 478:408-411.
32. Schulze A, Gripon P, Urban S. 2007. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 46:1759-1768.
33. Leistner CM, Gruen-Bernhard S, Glebe D. 2008. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol. 10:122-133.
34. Yi L, Fang J, Isik N, Chim J, Jin T. 2006. HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging. J. Biol. Chem. 281:35446-35453.
35. Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harbor Perspect. Med., in press. doi: 10.1101/cshperspect.a006866.
36. Sureau C, Salisse J. 2013. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57:985-994.
37. Salisse J, Sureau C. 2009. A function essential to viral entry underlies the hepatitis B virus "a" determinant. J. Virol. 83:9321-9328.
38. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. 2004. The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
39. Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
40. Neil SJ, Zang T, Bieniasz PD. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
41. Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT. 2010. Endogenous CD317/tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J. Virol. 84:11374-11384.
42. Moolla N, Kew M, Arbuthnot P. 2002. Regulatory elements of hepatitis B virus transcription. J. Viral Hepat. 9:323-331.
43. Lei YC, Hao YH, Zhang ZM, Tian YJ, Wang BJ, Yang Y, Zhao XP, Lu MJ, Gong FL, Yang DL. 2006. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. World J. Gastroenterol. 12:4492-4497.
44. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. 2005. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:8321-8326.
45. Vartanian JP, Henry M, Marchio A, Suspene R, Aynaud MM, Guetard D, Cervantes-Gonzalez M, Battiston C, Mazzaferro V, Pineau P, Dejean A, Wain-Hobson S. 2010. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog. 6:e1000928. doi:10.1371/journal.ppat.1000928.